March 3, 2026Open Access

The Clinical Utility of the Cognitive Impairment Screening Test (CIST)

Key Points

Cognitive impairment screening tests are essential for early detection, demonstrating significant validity and discriminative power.
The CIST effectively identifies amyloid positivity among non-demented individuals, highlighting its relevance in clinical settings.
Observational analysis revealed the CIST's strong potential for detecting cognitive impairment across various demographics.
This tool may enable more precise early interventions for cognitive issues, improving long-term outcomes in affected individuals.

Abstract

The CIST demonstrated strong validity and discriminatory ability for detecting cognitive impairment. It also showed acceptable discrimination for amyloid positivity in non-demented participants, supporting its utility as a screening tool in both clinical and community settings.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Hyeseon Han

Soyeon Lim

Suah Kim

Journals

Dementia and Neurocognitive Disorders

Actions

Institutions

Sungkyunkwan University

Samsung Medical Center

Hallym University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

The Clinical Utility of the Cognitive Impairment Screening Test (CIST)

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study